Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders
June 20 2014 - 3:00PM
Marketwired
Ceapro Announces Re-Election of Board Members at its Annual Meeting
of Shareholders
EDMONTON, ALBERTA--(Marketwired - Jun 20, 2014) - Ceapro Inc.
(TSX-VENTURE:CZO) ("Ceapro" or "the Company") announces that all
Directors, Edward Taylor, Don Oborowsky, Gilles Gagnon, Glenn
Rourke and John Zupancic, were re-elected to serve for another year
at its annual meeting of shareholders held on June 11, 2014.
All other matters at the shareholders' meeting, namely the
appointment of Auditors and the Re-approval and Ratification of
Stock Options Plan, were also approved by shareholders.
Also, each member of the board and an officer of the Comapny
have elected to exercise 100% of their options that were granted on
June 23, 2009.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company.
Primary business activities relate to the development and
commercialization of active ingredients for personal care and
cosmetic industries using proprietary technology and natural,
renewable resources. To learn more about Ceapro, visit
www.ceapro.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Ceapro Inc.Branko JankovicVice President and CFO(Edmonton):
780.917.8376bjankovic@ceapro.com
Ceapro (TSXV:CZO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ceapro (TSXV:CZO)
Historical Stock Chart
From Sep 2023 to Sep 2024